Rheumatoid arthritis: open trials in France

48 open trials have a site in France. Registry data; only the trial team decides who can take part.

2026-526117-28-00
Phase 1/2 study to evaluate the safety, pharmacokinetics, and preliminary efficacy of SAR447998 in adults with refractory Systemic Lupus Erythematosus or Rheumatoid Arthritis
Trial Treatment · Phase 1/2 · Sanofi-Aventis Recherche & Developpement
Centre Hospitalier Regional De Marseille, Marseille · Centre Hospitalier Universitaire De Montpellier, Montpellier Cedex 5 · Centre Hospitalier Universitaire de Bordeaux, Pessac
Registry updated 2026-10-30
NCT07624994
Functional Imaging of Digital Osteoarthritis and Rheumatoid Arthritis Using 99mTc-NTP 15-5 in Nuclear Medicine
Trial Treatment · Phase 2 · Centre Jean Perrin
Centre Jean Perrin, Clermont-Ferrand · CHU Clermont-Ferrand, Clermont-Ferrand
Registry updated 2026-10-20
NCT06916806
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
Trial Treatment · Phase 1 · AstraZeneca
Centre hospitalier Universitaire de Bordeaux, Bordeaux · Centre Hospitalier Universitaire de Montpellier, Montpellier · CHRU de Nancy, Nancy · Assistance Publique Hopitaux de Paris, Paris · Les Hopitaux Universitaires De Strasbourg, Strasbourg Cedex 2 · Centre Hospitalier Universitaire De Toulouse, Toulouse Cedex 9
Registry updated 2026-10-19
NCT07137598
A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)
Trial Treatment · Phase 2 · Hoffmann-La Roche
Hôpital de la Conception, Marseille · Hôpital LAPEYRONIE, Montpellier · Hpital Cochin, Paris · CHU Strasbourg Hpital Hautepierre, Strasbourg · Hopital Purpan, Toulouse
Registry updated 2026-10-16
NCT07620392
An Extension Study to Assess Long-Term Safety and Efficacy of Afimkibart in Participants With Rheumatoid Arthritis
Trial Treatment · Phase 2 · Hoffmann-La Roche
Centre Hospitalier Regional De Marseille, Marseille · Centre Hospitalier Universitaire De Montpellier, Montpellier Cedex 5 · Assistance Publique Hopitaux de Paris, Paris · Les Hopitaux Universitaires De Strasbourg, Strasbourg Cedex 2 · Centre Hospitalier Universitaire de Toulouse, Toulouse
Registry updated 2026-10-16
NCT07873931
A Study of BMS-986553 in Participants With Refractory Autoimmune Diseases
Trial Treatment · Phase 1 · Bristol-Myers Squibb
Montpellier · Paris
Registry updated 2026-10-14
NCT06570798
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
Trial Treatment · Phase 2 · Amgen
Hôpitaux Universitaires Paris Sud - Hôpital Bicêtre, Le Kremlin-Bicêtre · Centre Hospitalier Régional Universitaire de Lille - Hôpital Claude Huriez, Lille · Centre Hospitalier Universitaire de Lyon- Hopital Edouard Herriot, Lyon · Centre Hospitalier Universitaire de Lyon - Hopital Edouard Herriot, Lyon Cédex 3 · Hôpital de la Conception, Marseille · Hôpital Européen Georges Pompidou, Paris · Hôpital Bichat - Claude-Bernard, Paris · Hôpital Cochin, Paris · Centre Hospitalier Universitaire de Strasbourg - Hopital de Hautepierre, Strasbourg · Centre Hospitalier Universitaire de Strasbourg - Nouvel Hopital Civil, Strasbourg · Centre Hospitalier Universitaire de Toulouse - Hopital Purpan, Toulouse · Centre Hospitalier Universitaire de Toulouse - Hopital Rangueil, Toulouse
Registry updated 2026-10-05
NCT06876064
National Cohort of Subjects at Risk of Developing Rheumatoid Arthritis
Research · University Hospital, Montpellier
CHU Montpellier, Montpellier
Registry updated 2026-10-01
NCT05603728
Exactech Shoulder Post Market Clinical Follow-up Study
Research · Exactech
Clinique Belledone, Grenoble · Centre de l'arthrose, Mérignac · Clinique Mutualiste La Sagesse, Rennes
Registry updated 2026-09-17
2025-521034-28-00
A Study to Assess the Efficacy and Safety of RO7790121 in Patients with Moderate to Severe Rheumatoid Arthritis who have not Responded to or who Cannot Tolerate TNF and/or JAK Inhibitors
Trial Treatment · Phase 2 · F. Hoffmann-La Roche AG
Centre Hospitalier Regional De Marseille, Marseille · Centre Hospitalier Universitaire De Montpellier, Montpellier Cedex 5 · Hopital Cochin Saint Vincent De Paul, Paris · Les Hopitaux Universitaires De Strasbourg, Strasbourg Cedex 2 · Centre Hospitalier Universitaire de Toulouse, Toulouse
Registry updated 2026-09-14
NCT07544225
Study Investigating the Safety of Anti-CD19 CAR-T Cells Therapy Produced at Gustave Roussy for Adults With Severe and Refractory Systemic Autoimmune Rheumatic Diseases
Trial Treatment · Phase 1 · Gustave Roussy, Cancer Campus, Grand Paris
Gustave Roussy, Villejuif
Registry updated 2026-09-02
NCT06977724
A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE), Sjogren's Disease (SjD) and Rheumatoid Arthritis (RA)
Trial Treatment · Phase 1 · AbbVie
Centre Hospitalier Universitaire de Montpellier, Montpellier · Les Hopitaux Universitaires De Strasbourg, Strasbourg Cedex 2
Registry updated 2026-08-10
NCT06687551
JAK Inhibitor Dose TAPering Strategy Study
Trial Treatment · Phase 4 · University Hospital, Toulouse
Centre Hospitalier Universitaire Amiens Picardie, Amiens Cedex 1 · Centre hospitalier Universitaire de Bordeaux, Bordeaux · Centre Hospitalier Regional Et Universitaire De Brest, Brest Cedex 2 · Centre Hospitalier Regional Universitaire De Tours, Chambray Les Tours · University Hospital Of Clermont-Ferrand, Clermont Ferrand Cedex 1 · Assistance Publique Hopitaux De Paris, Le Kremlin-Bicetre · Centre Hospitalier Le Mans, Le Mans Cedex 9 · Centre Hospitalier Et Universitaire de Limoges, Limoges · Groupement Des Hopitaux De L'Institut Catholique De Lille, Lomme Cedex · Assistance Publique Hôpitaux de Marseille, Marseille · Centre Hospitalier Universitaire De Montpellier, Montpellier Cedex 5 · Centre Hospitalier Universitaire de Nice, Nice · Centre Hospitalier Regional D'orleans, Orleans Cedex 2 · Assistance Publique Hopitaux de Paris, Paris · Assistance Publique Hopitaux De Paris, Paris Cedex 10 · Assistance Publique Hopitaux De Paris, Paris Cedex 13 · GIE Groupe hospitalier Paris Saint-Joseph/Vinci, Paris Cedex 14 · Centre Hospitalier Universitaire Reims, Reims · CHU De Rouen, Rouen Cedex · Centre Hospitalier Universitaire de Saint Etienne, Saint-Priest-en-Jarez · Les Hopitaux Universitaires De Strasbourg, Strasbourg Cedex 2 · Centre Hospitalier Universitaire de Toulouse, Toulouse · CHRU De Nancy, Vandoeuvre Les Nancy Cedex
Registry updated 2026-08-07
NCT06991114
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
Trial Treatment · Phase 2 · Artiva Biotherapeutics, Inc.
Centre Hospitalier Regional De Marseille, Marseille · Hospital Saint Eloi, Montpellier · Centre Hospitalier Universitaire De Toulouse, Toulouse Cedex 9
Registry updated 2026-07-31
2025-523650-14-00
functional imaging of digital osteoarthritis and rheumatoid arthritis using 99mTc-NTP15-5 in nuclear medicine : phase II clinical study
Trial Treatment · Phase 2 · Centre Jean Perrin
University Hospital Of Clermont-Ferrand, Clermont-Ferrand · Centre Jean Perrin, Clermont-Ferrand
Registry updated 2026-07-24
NCT07115745
A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
Trial Treatment · Phase 1 · Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Centre Hospitalier Universitaire De Lille, Lille Cedex · Les Hopitaux Universitaires De Strasbourg, Strasbourg Cedex 2
Registry updated 2026-07-14
NCT02469662
Clinical Outcomes Study of the Nexel Total Elbow
Trial Treatment · Zimmer Biomet
Hôpital Purpan (Centre Hospitalier Universitaire Toulouse), Toulouse
Registry updated 2026-07-09
NCT07515638
Immun4Cure Cohort of Autoimmune Diseases
Research · University Hospital, Montpellier
CHU de Montpellier - CIMA, Montpellier
Registry updated 2026-06-30
NCT06551389
Follow-up of the Systemic Lupus Erythematosus Cohort as Part of the Multidisciplinary Consultation at Brest CHRU
Research · University Hospital, Brest
CHRU de Brest, Brest
Registry updated 2026-06-25
NCT06312943
"Translating Articular Biomarkers Into Diagnoses"
Research · Assistance Publique - Hôpitaux de Paris
Service de Médecine Physique et de Réadaptation, Hôpital Cochin, Paris
Registry updated 2026-06-24
NCT07371468
A Study of GSK5926371 in Participants With B-cell Driven Autoimmune Rheumatic Diseases (ARD)
Trial Treatment · Phase 1 · GlaxoSmithKline
Centre hospitalier Universitaire de Bordeaux, Bordeaux · Centre Hospitalier Universitaire De Toulouse, Toulouse Cedex 9
Registry updated 2026-06-23
NCT07077304
EACVI Study on Multimodality Cardiovascular Imaging of Inflammatory Cardiovascular Diseases
Research · Assistance Publique - Hôpitaux de Paris
Assistance Publique Hôpitaux de Paris, Paris, île de France 75010, Paris
Registry updated 2026-06-05
NCT07321340
Insole Optimization for Rheumatoid Arthritis Patients
Trial Treatment · Centre Hospitalier Universitaire de Saint Etienne
Chu de Saint Etienne, Saint-Etienne
Registry updated 2026-06-05
NCT07582185
Tdose Binding and Tocilizumab
Trial Treatment · Phase 4 · Centre Hospitalier Universitaire de Nice
Hôpital Saint Joseph, Marseille · Centre Hospitalier Universitaire de Nice, Nice
Registry updated 2026-05-12
NCT06235645
dEtection of rheumAtoid aRthritis - Interstitial Lung dIseasE by Thoracic ultRasound
Research · University Hospital, Tours
university hospital, Tours, Tours
Registry updated 2026-04-30

All Rheumatoid arthritis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error